CVS vs TEM · P/E 16, rev $402.07B vs rev $693.4M
CVS Health Corp (CVS) versus Tempus AI, Inc. Class A Common Stock (TEM) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Tempus AI, Inc. Class A Common Stock (TEM) is a health information services company listed on NASDAQ.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported TEM revenue for 2024-12-31 was $693.4M. Net income was -$705.8M. Revenue was up 30.4% from 2023-12-31 to 2024-12-31. TEM currently screens at market cap $8.76B.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. TEM currently screens at market cap $8.76B.
Not investment advice. Open the CVS and TEM stock pages for the full models.
Not investment advice.